Prospect Capital (PSEC) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
1 Jun, 2026Scale and portfolio diversification
Over $6.4B in total assets and $22B+ invested since 2004, with 89 investments across 31 industries.
One of the largest and longest-running listed BDCs, with a broad portfolio and significant scale advantage.
Portfolio weighted toward non-cyclical, defensive industries, with limited software exposure (3%).
84% of the portfolio is in senior and secured investments, with 72% first lien.
Sole or lead investor in 75% of the portfolio, supporting active management.
Investment strategy and performance
Focus on U.S. middle-market companies, primarily those with EBITDA up to $150M, with a current emphasis on sub-$50M EBITDA for less competitive opportunities.
Strategy prioritizes capital preservation, risk reduction, and avoidance of yield chasing.
12% exited gross IRR since inception, with 14.4% IRR for sub-$50M EBITDA investments.
Over 350 investment exits, with a disciplined underwriting process and less than 2% book-to-look ratio.
Non-accrual loans remain low at 0.7% of total assets.
Financial strength and risk management
72% total equity capitalization, with $4.6B in equity (common and preferred).
Low leverage: 28% debt-to-total-capital, 0.38x net debt to total equity, lower than listed BDC peers.
$1.8B undrawn revolver commitments and $4.2B unencumbered assets (65% of total assets).
Laddered liability structure with long-term matched-book funding; $2.1B credit facility matures in 2029.
Strong insider ownership at 27.5% of common stock, totaling $811M based on NAV.
Latest events from Prospect Capital
- Special meeting adjourned to June 23, 2026, to solicit more votes on key proposals.PSEC
Proxy filing9 Jun 2026 - Net investment income was $78.5M, with a focus on first lien loans and strong liquidity.PSEC
Q3 20268 May 2026 - Disciplined middle-market lender with strong credit quality, low leverage, and high insider ownership.PSEC
Investor presentation8 May 2026 - Shareholders are called to vote on a major operating initiative at the June 2026 special meeting.PSEC
Proxy filing16 Apr 2026 - Renewal of approval to issue stock below NAV aims to boost flexibility and shareholder value.PSEC
Proxy filing9 Apr 2026 - Proposal seeks renewed authority to sell common stock below NAV, with Board support and dilution risks.PSEC
Proxy Filing11 Mar 2026 - Shareholders are asked to approve limited sales of stock below net asset value for the next year.PSEC
Proxy Filing11 Mar 2026 - Robust middle-market lender with strong returns, low risk, and disciplined financial management.PSEC
Investor presentation2 Mar 2026 - Shareholders are asked to renew approval for below-NAV stock sales, capped at 25% per sale.PSEC
Proxy Filing27 Feb 2026